Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • gsk

    Tag: gsk

    You Searched For "gsk"
    GSK , Vir Biotechnology enter collaboration to find coronavirus solutions

    GSK , Vir Biotechnology enter collaboration to find coronavirus solutions

    Medical Dialogues Bureau12 April 2020 5:15 AM GMT
    London, UK and San Francisco, US: GlaxoSmithKline plc and Vir Biotechnology, Inc. have announced that they have signed a binding agreement to enter...
    Cipla completes Phase-3 clinical study for generic version of GSK Advair Diskus

    Cipla completes Phase-3 clinical study for generic version of GSK Advair Diskus

    Medical Dialogues Bureau5 April 2020 9:11 AM GMT
    Mumbai: Cipla Limited has announced the successful completion of the Phase-3 clinical end-point study for fluticasone propionate and salmeterol...
    HUL completes GSK merger, buys Horlicks in Rs 3,045 crores

    HUL completes GSK merger, buys Horlicks in Rs 3,045 crores

    Medical Dialogues Bureau4 April 2020 8:06 AM GMT
    Horlicks has a volume share of close to 50 per cent in the HFD market
    GSK India appoints Mr Sridhar Venkatesh as Managing Director & VP

    GSK India appoints Mr Sridhar Venkatesh as Managing Director & VP

    Medical Dialogues Bureau4 March 2020 12:13 PM GMT
    Mumbai: Mr Sridhar Venkatesh has been appointed as Managing Director & VP of GSK India effective 1 April 2020. He succeeds Mr Annaswamy Vaidheesh...
    EMA accepts GSK filing for Trelegy Ellipta use in adults with asthma

    EMA accepts GSK filing for Trelegy Ellipta use in adults with asthma

    Medical Dialogues Bureau4 March 2020 4:45 AM GMT
    once-daily single inhaler triple therapy available for asthma and COPD if approved
    More drugmakers including Gilead, Biogen, BMS to hike US prices for 50 drugs

    More drugmakers including Gilead, Biogen, BMS to hike US prices for 50 drugs

    Medical Dialogues Bureau2 Jan 2020 9:18 AM GMT
    New Delhi: Drugmakers including Bristol-Myers Squibb Co (BMY.N), Gilead Sciences Inc (GILD.O), and Biogen Inc (BIIB.O) hiked U.S. list prices on more...
    CDSCO declares 36 samples of Atorvastatin, Metformin, Paracetamol, others as Not of Standard Quality

    CDSCO declares 36 samples of Atorvastatin, Metformin, Paracetamol, others as Not of Standard Quality

    Farhat Nasim25 Nov 2019 10:11 AM GMT
    New Delhi: The nodal drug regulatory body, the Central Drugs Standard Control Organization (CDSCO) has declared batches of 36 drugs as not of standard...
    GSK Benlysta gets European nod for treatment of children with lupus

    GSK Benlysta gets European nod for treatment of children with lupus

    Medical Dialogues Bureau4 Nov 2019 3:45 AM GMT
    New Delhi: GlaxoSmithKline (GSK) plc recently announced that the European Commission has adopted a decision to extend to children five years and...
    Iconic Crocin Pain Relief to get a relaunch

    Iconic Crocin Pain Relief to get a relaunch

    Garima1 Nov 2019 8:19 AM GMT
    GSK markets five varients of Crocin namely Crocin Advance, Crocin 650 Mg, Crocin Pain Relief, Crocin Cold & Flu and Crocin's Children Range...
    GSK Pharma reports Q2 profit at Rs 503 crore

    GSK Pharma reports Q2 profit at Rs 503 crore

    Medical Dialogues Bureau1 Nov 2019 3:45 AM GMT
    GSK Pharmaceuticals continues to drive improved operational efficiencies reflecting in earnings before interest, tax, depreciation and amortisation...
    GSK lifts annual profit forecast after third quarter beat on vaccines strength

    GSK lifts annual profit forecast after third quarter beat on vaccines strength

    Medical Dialogues Bureau31 Oct 2019 3:30 AM GMT
    GSK now expects full-year profit to be roughly flat compared to last year at constant currency, up from a previous forecast of a fall of 3% to 5%.New...
    GSK ovarian cancer drug Zejula gets USFDA nod for wider use

    GSK ovarian cancer drug Zejula gets USFDA nod for wider use

    Medical Dialogues Bureau24 Oct 2019 4:30 AM GMT
    Zejula was the lead compound of U.S. cancer specialist Tesaro, which GSK acquired for $5.1 billion last year. Zejula brought in sales of 57 million...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier

    This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:

    Search only trustworthy HONcode health websites:

    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

    © 2020 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok